IL87834A - 2-substituted spiro(1,3-oxathiolane-4(and-5),3')quinuclidines and pharmaceutical compositions containing them - Google Patents
2-substituted spiro(1,3-oxathiolane-4(and-5),3')quinuclidines and pharmaceutical compositions containing themInfo
- Publication number
- IL87834A IL87834A IL87834A IL8783488A IL87834A IL 87834 A IL87834 A IL 87834A IL 87834 A IL87834 A IL 87834A IL 8783488 A IL8783488 A IL 8783488A IL 87834 A IL87834 A IL 87834A
- Authority
- IL
- Israel
- Prior art keywords
- hydrogen
- group
- sec
- oxathiolane
- quinuclidines
- Prior art date
Links
- 239000008194 pharmaceutical composition Substances 0.000 title 1
- 150000008584 quinuclidines Chemical class 0.000 title 1
- 125000003003 spiro group Chemical class 0.000 title 1
- 229910052739 hydrogen Inorganic materials 0.000 abstract 4
- 239000001257 hydrogen Substances 0.000 abstract 4
- 150000002431 hydrogen Chemical class 0.000 abstract 3
- 125000003342 alkenyl group Chemical group 0.000 abstract 2
- 125000000217 alkyl group Chemical group 0.000 abstract 2
- 125000000304 alkynyl group Chemical group 0.000 abstract 2
- 125000004103 aminoalkyl group Chemical group 0.000 abstract 2
- 125000003118 aryl group Chemical group 0.000 abstract 2
- 125000002768 hydroxyalkyl group Chemical group 0.000 abstract 2
- 125000006272 (C3-C7) cycloalkyl group Chemical group 0.000 abstract 1
- HBAQYPYDRFILMT-UHFFFAOYSA-N 8-[3-(1-cyclopropylpyrazol-4-yl)-1H-pyrazolo[4,3-d]pyrimidin-5-yl]-3-methyl-3,8-diazabicyclo[3.2.1]octan-2-one Chemical class C1(CC1)N1N=CC(=C1)C1=NNC2=C1N=C(N=C2)N1C2C(N(CC1CC2)C)=O HBAQYPYDRFILMT-UHFFFAOYSA-N 0.000 abstract 1
- YZCKVEUIGOORGS-OUBTZVSYSA-N Deuterium Chemical compound [2H] YZCKVEUIGOORGS-OUBTZVSYSA-N 0.000 abstract 1
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 abstract 1
- YZCKVEUIGOORGS-NJFSPNSNSA-N Tritium Chemical compound [3H] YZCKVEUIGOORGS-NJFSPNSNSA-N 0.000 abstract 1
- 239000002253 acid Substances 0.000 abstract 1
- 230000001713 cholinergic effect Effects 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 125000001995 cyclobutyl group Chemical group [H]C1([H])C([H])([H])C([H])(*)C1([H])[H] 0.000 abstract 1
- 125000000582 cycloheptyl group Chemical group [H]C1([H])C([H])([H])C([H])([H])C([H])([H])C([H])(*)C([H])([H])C1([H])[H] 0.000 abstract 1
- 125000001559 cyclopropyl group Chemical group [H]C1([H])C([H])([H])C1([H])* 0.000 abstract 1
- 229910052805 deuterium Inorganic materials 0.000 abstract 1
- 239000000032 diagnostic agent Substances 0.000 abstract 1
- 229940039227 diagnostic agent Drugs 0.000 abstract 1
- 239000003814 drug Substances 0.000 abstract 1
- 238000004519 manufacturing process Methods 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
- 229940124597 therapeutic agent Drugs 0.000 abstract 1
- 230000001225 therapeutic effect Effects 0.000 abstract 1
- 229910052722 tritium Inorganic materials 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D453/00—Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D497/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having oxygen and sulfur atoms as the only ring hetero atoms
- C07D497/12—Heterocyclic compounds containing in the condensed system at least one hetero ring having oxygen and sulfur atoms as the only ring hetero atoms in which the condensed system contains three hetero rings
- C07D497/20—Spiro-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Psychiatry (AREA)
- Hospice & Palliative Care (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Compositions Of Macromolecular Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicinal Preparation (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US11447387A | 1987-10-28 | 1987-10-28 | |
| US07/189,210 US4876260A (en) | 1987-10-28 | 1988-05-02 | Oxathiolanes |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| IL87834A0 IL87834A0 (en) | 1989-03-31 |
| IL87834A true IL87834A (en) | 1992-05-25 |
Family
ID=26812231
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL87834A IL87834A (en) | 1987-10-28 | 1988-09-22 | 2-substituted spiro(1,3-oxathiolane-4(and-5),3')quinuclidines and pharmaceutical compositions containing them |
Country Status (13)
| Country | Link |
|---|---|
| US (1) | US4876260A (xx) |
| EP (1) | EP0314444B1 (xx) |
| JP (1) | JP2753280B2 (xx) |
| KR (1) | KR910007979B1 (xx) |
| AT (1) | ATE138663T1 (xx) |
| AU (1) | AU608903B2 (xx) |
| CA (1) | CA1315791C (xx) |
| DE (1) | DE3855325T2 (xx) |
| DK (1) | DK175064B1 (xx) |
| ES (1) | ES2087854T3 (xx) |
| IL (1) | IL87834A (xx) |
| NO (1) | NO167806C (xx) |
| NZ (1) | NZ226415A (xx) |
Families Citing this family (19)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5852029A (en) * | 1990-04-10 | 1998-12-22 | Israel Institute For Biological Research | Aza spiro compounds acting on the cholinergic system with muscarinic agonist activity |
| US5534520A (en) * | 1990-04-10 | 1996-07-09 | Fisher; Abraham | Spiro compounds containing five-membered rings |
| JP2683783B2 (ja) * | 1992-07-10 | 1997-12-03 | 雪印乳業株式会社 | シェーグレン症候群治療剤 |
| DE4343838C2 (de) * | 1993-12-22 | 1998-07-09 | Lohmann Therapie Syst Lts | Deuteriertes Arzneimittel in transdermaler Applikation und Verfahren zu seiner Herstellung |
| US6479074B2 (en) | 1996-10-24 | 2002-11-12 | Pharmaceutical Applications Associates Llc | Methods and transdermal compositions for pain relief |
| US6572880B2 (en) | 1996-10-24 | 2003-06-03 | Pharmaceutical Applications Associates Llc | Methods and transdermal compositions for pain relief |
| US6290986B1 (en) | 1996-10-24 | 2001-09-18 | Pharmaceutical Applications Associates, Llc | Method and composition for transdermal administration of pharmacologic agents |
| JP2002500652A (ja) | 1997-05-30 | 2002-01-08 | ニューロサーアチ・アクティーゼルスカブ | スピロ−キヌクリジン誘導体、その製造方法及びその使用方法 |
| US20040209849A1 (en) * | 1998-11-27 | 2004-10-21 | Sanochemia Pharmazeutika Aktiengesellschaft | Use of effectors of the central cholinergic nervous system for treatment of delirium |
| JP4447685B2 (ja) * | 1999-01-14 | 2010-04-07 | 第一三共株式会社 | 皮膚乾燥症治療剤 |
| US6433168B1 (en) | 1999-07-26 | 2002-08-13 | Sumika Fine Chemicals Co., Ltd. | Highly pure phenothiazine compound, production method thereof, production method of intermediate therefor, and hydrate and novel crystal as starting materials for the intermediate |
| EP2320660B8 (en) | 2001-11-29 | 2015-09-09 | Godo Kaisha IP Bridge 1 | Coding distortion removal method |
| BR0309875A (pt) * | 2002-05-03 | 2007-04-10 | Israel Inst For Biolog Res Isr | métodos e composições para tratamento de distúrbios do sistema nervoso periférico e novos compostos úteis para isto |
| PE20080207A1 (es) * | 2006-06-20 | 2008-05-08 | Wyeth Corp | DERIVADOS DE 1-N-AMINO-2-IMIDAZOLIDINONAS COMO INHIBIDORES DEL CANAL DE POTASIO Kv1.5 |
| US8143400B2 (en) * | 2008-01-10 | 2012-03-27 | Apotex Pharmachem Inc. | Process for the preparation and purification of cis-2-methylspiro(1,3-oxathiolane-5,3′)quiniclidine hydrochloride |
| AP2011005725A0 (en) * | 2008-11-23 | 2011-06-30 | Pfizer | Lactams as beta secretase inhibitors. |
| US8673931B2 (en) | 2009-01-26 | 2014-03-18 | Abraham Fisher | Bicyclic heterocyclic spiro compounds |
| US9034891B2 (en) | 2009-01-26 | 2015-05-19 | Israel Institute For Biological Research | Bicyclic heterocyclic spiro compounds |
| CN101798311A (zh) * | 2010-04-07 | 2010-08-11 | 天津炜杰凯华科技有限公司 | 顺式西维美林的制备方法 |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2146962A1 (en) * | 1971-07-28 | 1973-03-09 | Yoshitomi Pharmaceutical | Aza-spirodecanones - useful in treating gastric disorders |
| IL48452A (en) * | 1975-11-11 | 1979-07-25 | Purdue Frederick Co | Spiro (1,3-dioxolane-4,3') quinuclidines,their preparationand pharmaceutical compositions comprising them |
| IL48453A (en) * | 1975-11-11 | 1980-06-30 | Purdue Frederick Co | Substituted 6-oxa-1-azatricyclo-(6.2.2.0 )dodecan-5-ones and 1,4-ethano-5-oxo octa (or decahydro)quinoline,their preparation and pharmaceutical compositions containing them |
| US4855290A (en) * | 1985-05-10 | 1989-08-08 | State Of Israel, Represented By Prime Minister's Office, Israel Institute For Biological Research | Derivatives of quinuclidine |
| ZA868369B (en) * | 1986-01-10 | 1987-11-25 | Israel State | Derivatives of quinuclidine |
| IL87234A (en) * | 1987-08-13 | 1992-02-16 | Israel Inst Biolog Res | Optical isomers of 2-methylspiro(1,3-oxathiolane-5,3')quinuclidine,their preparation and pharmaceutical compositions containing them |
-
1988
- 1988-05-02 US US07/189,210 patent/US4876260A/en not_active Expired - Lifetime
- 1988-09-22 IL IL87834A patent/IL87834A/xx active Protection Beyond IP Right Term
- 1988-09-30 NZ NZ226415A patent/NZ226415A/xx unknown
- 1988-10-12 AU AU23671/88A patent/AU608903B2/en not_active Expired
- 1988-10-26 EP EP88310040A patent/EP0314444B1/en not_active Expired - Lifetime
- 1988-10-26 DE DE3855325T patent/DE3855325T2/de not_active Expired - Lifetime
- 1988-10-26 AT AT88310040T patent/ATE138663T1/de not_active IP Right Cessation
- 1988-10-26 ES ES88310040T patent/ES2087854T3/es not_active Expired - Lifetime
- 1988-10-27 NO NO884790A patent/NO167806C/no not_active IP Right Cessation
- 1988-10-27 DK DK198805986A patent/DK175064B1/da not_active IP Right Cessation
- 1988-10-27 CA CA000581526A patent/CA1315791C/en not_active Expired - Lifetime
- 1988-10-28 KR KR1019880014136A patent/KR910007979B1/ko not_active Expired
- 1988-10-28 JP JP63271085A patent/JP2753280B2/ja not_active Expired - Lifetime
Also Published As
| Publication number | Publication date |
|---|---|
| ATE138663T1 (de) | 1996-06-15 |
| NO167806C (no) | 1991-12-11 |
| KR910007979B1 (ko) | 1991-10-05 |
| CA1315791C (en) | 1993-04-06 |
| DE3855325D1 (de) | 1996-07-04 |
| DE3855325T2 (de) | 1996-10-10 |
| DK598688A (da) | 1989-04-29 |
| ES2087854T3 (es) | 1996-08-01 |
| NO884790D0 (no) | 1988-10-27 |
| JP2753280B2 (ja) | 1998-05-18 |
| JPH0262883A (ja) | 1990-03-02 |
| KR890006641A (ko) | 1989-06-15 |
| AU2367188A (en) | 1989-05-04 |
| DK598688D0 (da) | 1988-10-27 |
| NZ226415A (en) | 1990-05-28 |
| NO884790L (no) | 1989-05-02 |
| EP0314444A2 (en) | 1989-05-03 |
| DK175064B1 (da) | 2004-05-17 |
| EP0314444A3 (en) | 1990-11-07 |
| EP0314444B1 (en) | 1996-05-29 |
| IL87834A0 (en) | 1989-03-31 |
| NO167806B (no) | 1991-09-02 |
| US4876260A (en) | 1989-10-24 |
| AU608903B2 (en) | 1991-04-18 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL87834A (en) | 2-substituted spiro(1,3-oxathiolane-4(and-5),3')quinuclidines and pharmaceutical compositions containing them | |
| GB2236751B (en) | Heterocyclic compounds | |
| PH21696A (en) | 1,8-naphthyridine derivatives,pharmaceutical composition containing the same and method of use therof | |
| JO1184B1 (en) | Therapeutic agents | |
| ES8705443A1 (es) | Procedimiento para la obtencion de poli-hidro piridazo diacepinas, triacepinas o diazocinas | |
| HUT40101A (en) | Process for producing quinolin-carboxylic acid derivatives and pharmaceutical compositions containing them as active agents | |
| EP0404737A3 (en) | New r(-) 3-quinuclidinol derivatives | |
| EP0309425A3 (en) | New heterocyclic derivatives | |
| MY103502A (en) | Novel compounds | |
| PH21976A (en) | New 5,11-dihydro-6h-pyrido-(2,3-b)(1,4) benzodiazepin-6-ones substituted in the 11-position and pharmaceutical compositions containing these compounds | |
| HUT75647A (en) | Imidazolidinone derivatives and pharmaceutical compositions containing them, which are suitable for treament of senile dementia | |
| ES8305359A1 (es) | Un procedimiento para la preparacion de benzamitas sustituidas. | |
| IL93051A0 (en) | ((5-oxo-2-pyrrolidinyl)methyl)cyclohexaneacetamides,their preparation and pharmaceutical compositions containing them | |
| DE3161640D1 (en) | Propanol amine, derivatives, process for their preparation and medicines containing these compounds | |
| NZ217276A (en) | Bicyclic heterocyclic compounds and pharmaceutical compositions | |
| SE8406046D0 (sv) | New azabiocyclic compounds and a process for the preparation thereof | |
| IL82946A (en) | 1-t-butyl-6-methylergoline-8-methanol derivatives,their preparation and pharmaceutical compositions containing them | |
| GEP19970835B (en) | Process for obtaining 3-(methyltio, methylsulphinyl or methylsulphonyl)-4-quinolone | |
| JO1825B1 (en) | Therapeutic agents |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| KB | Patent renewed | ||
| KB | Patent renewed | ||
| KB | Patent renewed | ||
| EXTN | Extension order renewed |